Long-term efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients harboring MET exon 14 skipping mutations.

Kato, Yasuhiro; Yamamoto, Gou; Watanabe, Yasutaka; Yamane, Yuki; Mizutani, Hideaki; Kurimoto, Futoshi; Seike, Masahiro; Gemma, Akihiko; Akagi, Kiwamu; Sakai, Hiroshi

Kato, Yasuhiro; Yamamoto, Gou; Watanabe, Yasutaka; Yamane, Yuki; Mizutani, Hideaki; Kurimoto, Futoshi; Seike, Masahiro; Gemma, Akihiko; Akagi, Kiwamu; Sakai, Hiroshi.

Afiliação

Kato Y; Department of Thoracic Oncology, Saitama Cancer Center, 780, Komuro, Ina, Kitaadachi, Saitama, 362-0806, Japan. y-kato@nms.ac.jp.
Yamamoto G; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan. y-kato@nms.ac.jp.
Watanabe Y; Department of Molecular Diagnosis and Cancer Prevention, Saitama Cancer Center, Saitama, Japan.
Yamane Y; Department of Thoracic Oncology, Saitama Cancer Center, 780, Komuro, Ina, Kitaadachi, Saitama, 362-0806, Japan.
Mizutani H; Department of Thoracic Oncology, Saitama Cancer Center, 780, Komuro, Ina, Kitaadachi, Saitama, 362-0806, Japan.
Kurimoto F; Department of Thoracic Oncology, Saitama Cancer Center, 780, Komuro, Ina, Kitaadachi, Saitama, 362-0806, Japan.
Seike M; Department of Thoracic Oncology, Saitama Cancer Center, 780, Komuro, Ina, Kitaadachi, Saitama, 362-0806, Japan.
Gemma A; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Akagi K; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Sakai H; Department of Molecular Diagnosis and Cancer Prevention, Saitama Cancer Center, Saitama, Japan.